Legal Disclosure
Impressum & Attribution
Institutional Governance
CardioFlow Lab is operated by CardioFlow Research AG, a registered entity in Zurich, Switzerland. Our commitment to scientific integrity is upheld by an independent editorial board comprising leading cardiovascular specialists, ensuring all content meets the highest clinical standards.
The scientific direction is overseen by Dr. Elara Vance, Chief Medical Officer, ensuring adherence to evidence-based protocols and the latest advancements in arterial longevity research. Regulatory identification: CHE-123.456.789.